ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.

Zhejiang Garden Biopharmaceutical Co.,Ltd.

300401

CNE100001XX7

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
10.97 ^CNY	+1.01%		-2.05%	-7.11%

Apr. 15	Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 20	Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Approves Final Cash Dividend for the Year 2021

April 20, 2022 at 03:33 pm EDT

Zhejiang Garden Bio-chemical High-tech Co., Ltd. approved final cash dividend of CNY 1.8800000 per 10 shares (tax included) for the year 2021, at the AGM held on April 19, 2022.

Latest news about Zhejiang Garden Biopharmaceutical Co.,Ltd.

Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 15	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.	Mar. 07	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback announced on September 14, 2023, has completed with 9,307,200 shares, representing 1.7% for CNY 100 million.	Mar. 05	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Announces Board Appointments	Feb. 23	CI
Zhejiang Garden Biopharmaceutical's Unit Gets Nod for Eight New Products	Feb. 05	MT
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.	Jan. 03	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-20	CI
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.	23-10-11	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on September 7, 2023.	23-09-14	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	23-08-22	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. authorizes a Buyback Plan.	23-08-21	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-07	CI
Zhejiang Garden Biopharma Registers Acid Reflux Drug	23-08-04	MT
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 24, 2023	23-05-18	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. has Changed its Name to Zhejiang Garden Biopharmaceutical Co., Ltd	23-04-28	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Approves Cash Dividend for the Year 2022	23-04-18	CI
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Proposes Final Cash Dividend for the Year 2022	23-03-27	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. announced a financing transaction	23-02-13	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-21	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-15	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Announces 2021 Final Cash Profit Distribution Plan on A Shares, Payable on 18 May 2022	22-05-12	CI
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Approves Final Cash Dividend for the Year 2021	22-04-20	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-20	CI

Chart Zhejiang Garden Biopharmaceutical Co.,Ltd.

Duration

Period

Chart Zhejiang Garden Biopharmaceutical Co.,Ltd.

More charts

Zhejiang Garden Biopharmaceutical Co Ltd, formerly Zhejiang Garden Bio-chemical High-tech Co Ltd, is a China-based company mainly engaged in the research, development, production and sales of vitamin D3 upstream and downstream products. The Company's vitamin products mainly include lanolin cholesterol, food and pharmaceutical grade vitamin D3, 25-hydroxyvitamin D3 and others. The Company also focuses on the research and development, production and sales of high-tech barrier preparations in the fields of cardiovascular, nervous system and other chronic diseases. The other products of the Company include Levofloxacin Tablets, Doxofylline Injection, Lipoic Acid Injection, Escitalopram Oxalate Tablets and others.

Sector

Pharmaceuticals

Calendar

2024-05-06 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.	-7.11%	809M
OTSUKA HOLDINGS CO., LTD.	+18.59%	22.25B
SANDOZ GROUP AG	+13.49%	14.39B
CIPLA LIMITED	+12.83%	13.55B
ZYDUS LIFESCIENCES LIMITED	+38.02%	11.27B
ONO PHARMACEUTICAL CO., LTD.	-9.80%	6.95B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+6.29%	5.01B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-5.36%	4.51B

Generic Pharmaceuticals

Zhejiang Garden Biopharmaceutical Co.,Ltd.

Equities

300401

CNE100001XX7

Pharmaceuticals

Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Approves Final Cash Dividend for the Year 2021

Latest news about Zhejiang Garden Biopharmaceutical Co.,Ltd.

Chart Zhejiang Garden Biopharmaceutical Co.,Ltd.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Generic Pharmaceuticals